Trying to compose the puzzle with all th
β
Massimo Di Maio; Cesare Gridelli; Nicola Normanno; Francesco Perrone; Fortunato
π
Article
π
2005
π
John Wiley and Sons
π
English
β 162 KB
## Abstract Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have shown promising activity in patients with nonβsmall cell lung cancer (NSCLC). Gefitinib has been the first of these drugs to be licensed for thirdβline treatment of advanced NSCLC patients. Mor